1887

Abstract

Summary.

The development of non-specific resistance to gentamicin, tobramycin and amikacin was studied in 12 clinical isolates of entero-bacteria with various patterns of aminoglycoside resistance. Strains were characterised with respect to MIC, transferability of resistance and possession of acetylating and adenylylating enzymes.

An increase in aminoglycoside resistance was induced in 10 strains by a single exposure to the concentration of gentamicin, tobramycin or amikacin immediately below the MIC. Such resistance was non-specific; all three aminoglycosides were affected irrespective of which one had been used to induce the increase. Increments in non-specific aminoglycoside resistance were also evoked by exposure of enterobacteria to changing drug concentrations similar to those achieved in plasma during therapy. When strains already resistant to gentamicin or other aminoglycosides were exposed to therapeutically achievable drug concentrations, no further increase in resistance was observed in most cases. This suggests that use of an aminoglycoside to which the organism is resistant, as during “blind” therapy, will not usually compromise subsequent treatment with related antibiotics. The possible relevance of non-specific aminoglycoside resistance to therapy is discussed.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-14-2-171
1981-05-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/14/2/medmicro-14-2-171.html?itemId=/content/journal/jmm/10.1099/00222615-14-2-171&mimeType=html&fmt=ahah

References

  1. Al-Asadi M. J. S., Greenwood D., O’Grady F. 1979.; In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection. Antimicrob. Agents Chemother 16:77
    [Google Scholar]
  2. Amirak I. D., Williams R. J., Noone P., Wills M. R. 1977; Amikacin resistance developing in patient with Pseudomonas aeruginosa bronchopneumonia. Lancet 1:537
    [Google Scholar]
  3. Benveniste R., Davies J. 1973; Mechanisms of antibiotic resistance in bacteria. Ann. Rev. Biochem 42:471
    [Google Scholar]
  4. Bodey G. P., Middleman E., Unsawadi T., Rodriguez V. 1972; Infections in cancer patients: results with gentamicin sulfate therapy. Cancer 29:1697
    [Google Scholar]
  5. Bryan L. E., Haraphongse R., Van den Elzen H. M. 1976; Gentamicin resistance in clinical isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification. J. Antibiot., Tokyo 29:743
    [Google Scholar]
  6. Bryan L. E., Shahrabadi M. S., Van den Elzen H. M. 1974; Gentamicin resistance in Pseudomonas aeruginosa: R-factor mediated resistance. Antimicrob. Agents Chemother 6:191
    [Google Scholar]
  7. Bryan L. E., Van den Elzen H. M. 1976; Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa . Antimicrob. Agents Chemother 9:928
    [Google Scholar]
  8. Houang E. T., Greenwood D. 1977; Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria. J. clin. Path 30:738
    [Google Scholar]
  9. Hughes C., Meynell G. G. 1977; Rapid screening for plasmid DNA. Molec. gen. Genet 151:175
    [Google Scholar]
  10. Mackintosh I. P., O’Grady F., Greenwood D., Watson B. W., Crichton T. C., Piper R., Ferrer A. 1973; A twelve channel bacterial growth monitoring system. Biomed. Eng. 8:514
    [Google Scholar]
  11. Mawer S. L., Greenwood D. 1977; Aminoglycoside resistance emerging during therapy. Lancet 1:749
    [Google Scholar]
  12. Mawer S. L., Greenwood D. 1978; Specific and non-specific resistance to aminoglycosides in Escherichia coli . J. clin. Path 31:12
    [Google Scholar]
  13. Meyer R. D. 1977; Patterns and mechanisms of emergence of resistance to amikacin. J. infect. Dis 136:449
    [Google Scholar]
  14. Murray B. E., Moellering R. C. 1979; Aminoglycoside-modifying enzymes among clinical isolates of Acinetobacter calcoaceticus subsp. anitratus (Herellea vaginicola): explanation for high-level aminoglycoside resistance. Antimicrob. Agents Chemother 15:190
    [Google Scholar]
  15. Phillips I., King B. A., Shannon K. P. 1978; The mechanisms of resistance to aminoglycosides in the genus Pseudomonas . J. Antimicrob. Chemother 4:121
    [Google Scholar]
  16. Seal D. V., Strangeways J. E. M. 1975; Resistant pseudomonads in a neurosurgical unit. Lancet 1:48
    [Google Scholar]
  17. Seal D. V., Strangeways J. E. M. 1977; Aminoglycoside resistance due to mutation. Lancet 1:856
    [Google Scholar]
  18. Shannon K. P., Phillips I., King B. A. 1978; Aminoglycoside resistance among Enterobacteriaceae and Acinetobacter species. J. Antimicrob. Chemother 4:131
    [Google Scholar]
  19. Thorbjarnardóttir S. H., Magnusdóttir R. A., Eggertsson G., Kagan S. A., Andresson O. S. 1978; Mutations determining generalized resistance to aminoglycoside antibiotics in Escherichia coli . Molec. gen. Genet 161:89
    [Google Scholar]
  20. Vogel H. J., Bonner D. M. 1956; A convenient growth medium for Escherichia coli and some other microorganisms (medium Ε). Microb. Genet. Bull 13:43
    [Google Scholar]
  21. Weinstein M. J., Drube C. G., Moss E. L., Waitz J. A. 1971; Microbiologie studies related to bacterial resistance to gentamicin. J. infect. DisDecember 124:S11
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-14-2-171
Loading
/content/journal/jmm/10.1099/00222615-14-2-171
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error